AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN)

AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN) Subsidiary Atrium Biotechnologies Inc. has filed prospectus in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. (CDN)
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005. ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double. ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double. Reliv International Announces Executive Promotion Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects. Reliv International Announces Executive Promotion Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects. Reliv International Announces Executive Promotion Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects. Reliv International Announces Executive Promotion Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects. Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005 Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal. Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005 Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal. Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005 Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal. Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005 Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal. Frutarom Reports 2004 Results Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million. Frutarom Reports 2004 Results Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million. CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc. As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ. CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc. As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ. Natural Health Trends Corp. Announces Fiscal 2004 Results Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses. Natural Health Trends Corp. Announces Fiscal 2004 Results Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses. COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005. COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005. COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005. COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005. AMS Health Sciences Launches Retail Merchant Division Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices. AMS Health Sciences Launches Retail Merchant Division Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices. Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc. Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors. Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc. Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors. Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc. Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors. Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc. Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors. Reliv International Names Managing Director for U.K./Ireland Operations Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland. Reliv International Names Managing Director for U.K./Ireland Operations Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland. Reliv International Names Managing Director for U.K./Ireland Operations Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland. Reliv International Names Managing Director for U.K./Ireland Operations Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland. Gateway Announces International Distribution Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia. Gateway Announces International Distribution Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia. New Zealand Milk becomes Fonterra Brands Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands. New Zealand Milk becomes Fonterra Brands Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands. Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year. Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year. Lifeway Foods Reports Year End Results Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003. Lifeway Foods Reports Year End Results Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003. Pure World Announces Results for 2004 Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003. Pure World Announces Results for 2004 Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003. Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each. Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each. Allergy Research Group, Inc. Reports 2004 Results Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003. Allergy Research Group, Inc. Reports 2004 Results Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003. Dynamic Health Products Completes Acquisition of Dynamic Marketing, Inc. Company completes previously announced acquisition. Dynamic Health Products Completes Acquisition of Dynamic Marketing, Inc. Company completes previously announced acquisition. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter. Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million. Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million. Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. Whole Living Reports 2004 Year End Results Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	QUEBEC CITY, Canada, March 29, 2005 /PRNewswire-FirstCall via COMTEX/ -- AEterna Zentaris Inc. (CA:AEZ)(AEZS) today announced that its 61.1%-owned subsidiary, Atrium Biotechnologies Inc. (TSX: ATB.sv), has filed a final prospectus with the securities regulatory authorities in each of the provinces of Canada in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. The offering consists of 4,166,667 subordinate voting shares to be issued from Atrium's treasury, for gross proceeds to Atrium of $50 million, and 2,083,333 subordinate voting shares to be sold by SGF Soquia Inc., a subsidiary of Societe generale de financement du Quebec, for gross proceeds to SGF Soquia Inc. of $25 million. The 6,250,000 subordinate voting shares will be sold to a syndicate of underwriters co-led by RBC Dominion Securities Inc. and National Bank Financial Inc., and including BMO Nesbitt Burns Inc., CIBC World Markets Inc., GMP Securities Ltd., HSBC Securities (Canada) Inc. and Loewen, Ondaatje, McCutcheon Limited. The offering is expected to close on April 6, 2005, at which time Atrium's subordinate voting shares will commence trading on the Toronto Stock Exchange under the symbol "ATB.sv". Atrium and SGF Soquia Inc., on a pro rata basis, have granted the underwriters an option to acquire up to 937,500 additional subordinate voting shares, representing 15% of the number of shares to be sold at the closing of the offering, to cover over-allotments and for market stabilization. The over- allotment option may be exercised at the offering price of $12 per share for a period of 30 days from the closing of the offering. Should the over-allotment option be exercised in full, the total gross proceeds of the offering will be $86.25 million, of which $57.5 million would be received by Atrium and $28.75 million would be received by SGF Soquia Inc. Following the completion of this offering and without giving effect to the exercise of the over-allotment option, Atrium will have 14,000,000 multiple voting shares and 14,692,915 subordinate voting shares issued and outstanding, for a total of 28,692,915 shares. AEterna Zentaris will hold 14,000,000 multiple voting shares and 537,996 subordinate voting shares for a total of 14,537,996 shares, representing 66.8% of the voting rights and 50.7% of the total equity of Atrium. Atrium's subordinate voting shares have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S registration or an applicable exemption from U.S. registration requirements. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy focused biopharmaceutical company with proven expertise in drug discovery, development and commercialization. The Company's broad 20 product pipeline leverages five different therapeutic approaches, including LHRH antagonists and signal transduction inhibitors. The lead LHRH antagonist compound, cetrorelix, is currently marketed for in vitro fertilization under the brand name Cetrotide(R). Cetrorelix is also in late-stage clinical development for endometriosis and benign prostatic hyperplasia (BPH). The lead signal transduction inhibitor compound, perifosine, is an orally-active AKT inhibitor that is in several Phase II trials for multiple cancers. AEterna Zentaris owns 61.1% of Atrium Biotechnologies Inc. (TSX: ATB.sv), a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutritional industries. News releases and additional information about AEterna Zentaris are available on its Web site www.aeternazentaris.com . Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward- looking statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software